Bank Of New York Mellon Corp Beyond Spring Inc. Transaction History

Bank Of New York Mellon Corp

  • $521 Trillion
  • Q1 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.13 - $2.66 $59,755 - $140,663
-52,881 Closed
0 $0
Q1 2022

May 11, 2022
SELL
$1.68 - $5.01 $4,376 - $13,051
-2,605 Reduced 4.69%
52,881 $117,000
Q4 2021

Feb 11, 2022
BUY
$4.02 - $16.84 $1,889 - $7,914
470 Added 0.85%
55,486 $251,000
Q3 2021

Nov 12, 2021
BUY
$9.26 - $31.31 $70,431 - $238,143
7,606 Added 16.04%
55,016 $867,000
Q2 2021

Aug 11, 2021
BUY
$9.37 - $12.12 $53,624 - $69,362
5,723 Added 13.73%
47,410 $494,000
Q1 2021

May 13, 2021
BUY
$10.61 - $15.77 $42,047 - $62,496
3,963 Added 10.51%
41,687 $461,000
Q4 2020

Feb 09, 2021
BUY
$10.21 - $17.31 $63,220 - $107,183
6,192 Added 19.64%
37,724 $460,000
Q3 2020

Nov 12, 2020
BUY
$9.99 - $16.13 $1,778 - $2,871
178 Added 0.57%
31,532 $419,000
Q2 2020

Aug 12, 2020
BUY
$11.21 - $18.15 $24,673 - $39,948
2,201 Added 7.55%
31,354 $472,000
Q1 2020

May 06, 2020
BUY
$9.68 - $18.47 $14,413 - $27,501
1,489 Added 5.38%
29,153 $373,000
Q4 2019

Feb 14, 2020
BUY
$11.83 - $18.68 $40,020 - $63,194
3,383 Added 13.93%
27,664 $428,000
Q3 2019

Nov 07, 2019
BUY
$15.33 - $23.85 $38,370 - $59,696
2,503 Added 11.49%
24,281 $439,000
Q2 2019

Aug 12, 2019
BUY
$13.36 - $23.7 $290,954 - $516,138
21,778 New
21,778 $516,000

Others Institutions Holding BYSI

# of Institutions
24
Shares Held
5.44M
Call Options Held
30.3K
Put Options Held
1.8K
View Full List

About BeyondSpring Inc.

BYSI Quotes by TradingView
  • Ticker BYSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,928,900
  • Market Cap $95.4M
  • Description
  • BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...
More about BYSI
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email